Form 8-K - Current report:
SEC Accession No. 0001125345-22-000003
Filing Date
2022-01-07
Accepted
2022-01-06 18:46:55
Documents
12
Period of Report
2022-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20220105.htm   iXBRL 8-K 31297
  Complete submission text file 0001125345-22-000003.txt   168461

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20220105.xsd EX-101.SCH 1911
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20220105_lab.xml EX-101.LAB 24977
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20220105_pre.xml EX-101.PRE 13185
6 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20220105_htm.xml XML 10830
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 22516074
SIC: 2834 Pharmaceutical Preparations